Trulieve Cannabis, traded as TRLV on the NYSE, has been the subject of various investment analyses and news reports. Some outlets have discussed the company's potential for breaking even and shifts in its investment narrative, possibly due to expansion and cost-cutting efforts. The company has also recently announced its uplisting to the New York Stock Exchange.